Ramesh Subrahmanyam, Ph.D. - Publications

Affiliations: 
2003 Brandeis University, Waltham, MA, United States 
Area:
Molecular Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Subrahmanyam R, Sen R. RAGs' eye view of the immunoglobulin heavy chain gene locus. Seminars in Immunology. 22: 337-45. PMID 20864355 DOI: 10.1016/J.Smim.2010.08.003  0.333
2009 Osipovich OA, Subrahmanyam R, Pierce S, Sen R, Oltz EM. Cutting edge: SWI/SNF mediates antisense Igh transcription and locus-wide accessibility in B cell precursors. Journal of Immunology (Baltimore, Md. : 1950). 183: 1509-13. PMID 19596997 DOI: 10.4049/Jimmunol.0900896  0.328
2009 Chakraborty T, Perlot T, Subrahmanyam R, Jani A, Goff PH, Zhang Y, Ivanova I, Alt FW, Sen R. A 220-nucleotide deletion of the intronic enhancer reveals an epigenetic hierarchy in immunoglobulin heavy chain locus activation. The Journal of Experimental Medicine. 206: 1019-27. PMID 19414554 DOI: 10.1084/Jem.20081621  0.336
2008 Fredericks J, Parikh C, Subrahmanyam R, Ren R. The RALGEF Pathway Contributes to the Pathogenesis of Chronic Myelogenous Leukemia by BCR/ABL Blood. 112: 3208-3208. DOI: 10.1182/Blood.V112.11.3208.3208  0.673
2007 Liu Y, Subrahmanyam R, Chakraborty T, Sen R, Desiderio S. A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity. 27: 561-71. PMID 17936034 DOI: 10.1016/J.Immuni.2007.09.005  0.304
2007 Chakraborty T, Chowdhury D, Keyes A, Jani A, Subrahmanyam R, Ivanova I, Sen R. Repeat organization and epigenetic regulation of the DH-Cmu domain of the immunoglobulin heavy-chain gene locus. Molecular Cell. 27: 842-50. PMID 17803947 DOI: 10.1016/J.Molcel.2007.07.010  0.303
2007 Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice. Cancer Research. 67: 7139-46. PMID 17671181 DOI: 10.1158/0008-5472.Can-07-0778  0.672
2006 Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice. Blood. 108: 2349-57. PMID 16763213 DOI: 10.1182/Blood-2004-08-009498  0.712
2006 Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS, KRAS, and HRAS Induce Distinct Hematological Diseases in Mice. Blood. 108: 1444-1444. DOI: 10.1182/Blood.V108.11.1444.1444  0.698
2001 Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R. The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Molecular and Cellular Biology. 21: 840-53. PMID 11154271 DOI: 10.1128/Mcb.21.3.840-853.2001  0.637
2000 Subrahmanyam R, Ren R. Activated N-RAS efficiently and rapidly induces multiple hematologic neoplasia in mice and complements the GRB2-SH2 binding site mutation of BCR-ABL in inducing a fatal myeloproliferative disorder Blood. 96: 92a.  0.511
Show low-probability matches.